1,051 results

1. pAAV-EF1a-vCre (AAV8)

   Viral Prep

   #55638-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-EF1a-vCre (#55638). In addition to the viral particles, you will also receive purified pAAV-EF1a-vCre plasmid DNA. EF1a-driven expression of VCre. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

   Promoter

   EF1a

   Available Since

   Nov. 12, 2020

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-mDlx-NLS-mRuby2 (AAV8)

   Viral Prep

   #99130-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-mDlx-NLS-mRuby2 (#99130). In addition to the viral particles, you will also receive purified pAAV-mDlx-NLS-mRuby2 plasmid DNA. mDlx-driven NLS-mRuby2 expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

   Promoter

   mDLX5/6

   Tags

   mRuby2

   Available Since

   May 12, 2023

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-hSyn-GRAB_OTmut (AAV9)

   Viral Prep

   #185388-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSyn-GRAB_OTmut (#185388). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB_OTmut plasmid DNA. hSyn-driven expression of the genetically-encoded fluorescent oxytocin(OT) control sensor GRAB_OTmut in neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Yulong Li

   Article

   Qian et al Nat Biotechnol. 2023 Jan 2. doi: 10.1038

   Promoter

   Syn

   Available Since

   June 26, 2024

   Availability

   Academic Institutions and Nonprofits only

4. pENN.AAV.CB7.CI.eGFP.WPRE.rBG (AAV5)

   Viral Prep

   #105542-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pENN.AAV.CB7.CI.eGFP.WPRE.rBG (#105542). In addition to the viral particles, you will also receive purified pENN.AAV.CB7.CI.eGFP.WPRE.rBG plasmid DNA. CB7-driven eGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CB7

   Tags

   EGFP

   Available Since

   July 24, 2018

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 (AAV9)

   Viral Prep

   #98932-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 (#98932). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent glutamate sensor. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger

   Article

   Marvin et al Nat Methods. 2013 Feb;10(2):162-70. doi:

   Promoter

   CAG

   Available Since

   Feb. 28, 2018

   Availability

   Academic Institutions and Nonprofits only

6. AAV pTRE-FSF-FLEX-EGFP-WPRE-bGHpA (AAV1)

   Viral Prep

   #65453-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from AAV pTRE-FSF-FLEX-EGFP-WPRE-bGHpA (#65453). In addition to the viral particles, you will also receive purified AAV pTRE-FSF-FLEX-EGFP-WPRE-bGHpA plasmid DNA. TRE-driven, Cre and Flp-dependent expression of EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Hongkui Zeng

   Article

   Madisen et al Neuron. 2015 Mar 4;85(5):942-58. doi: 10

   Promoter

   tetO

   Tags

   EGFP (Cre and Flp-dependent)

   Available Since

   Feb. 14, 2022

   Availability

   Academic Institutions and Nonprofits only

7. AAV-hSyn-Soma-jGCaMP8f (AAV Retrograde)

   Viral Prep

   #169258-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from AAV-hSyn-Soma-jGCaMP8f (#169258). In addition to the viral particles, you will also receive purified AAV-hSyn-Soma-jGCaMP8f plasmid DNA. Synapsin-driven neuronal expression of soma-targeted calcium sensor jGCaMP8f. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Marianne Fyhn

   Article

   Grodem et al Nat Commun. 2023 Feb 4;14(1):608. doi: 1

   Available Since

   March 18, 2024

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-nEF-Con/Fon/Von eYFP (AAV8)

   Viral Prep

   #137164-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-nEF-Con/Fon/Von eYFP (#137164). In addition to the viral particles, you will also receive purified pAAV-nEF-Con/Fon/Von eYFP plasmid DNA. nEF-driven, Cre, Flp and VCre-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth, INTRSECT 2.0 Project

   Article

   Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

   Promoter

   nEF

   Tags

   EYFP (Cre, Flp and VCre-dependent)

   Available Since

   Nov. 12, 2020

   Availability

   Academic Institutions and Nonprofits only

9. pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (AAV1)

   Viral Prep

   #218873-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (#218873). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project

   Article

   Kolb et al bioRxiv 2025.03.25.644953

   Promoter

   GFAP

   Available Since

   Sept. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pTR-UF11 (AAV.A10.T)

    Viral Prep

    #157970-AAV.A10.T

    Purpose

    Ready-to-use AAV6(dbY-F+T-V) in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter

    Depositor

    Sergei Zolotukhin

    Article

    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10

    Promoter

    chimeric CMV/Chicken Beta actin (CBA)

    Tags

    GFP

    Available Since

    Dec. 21, 2020

    Availability

    Academic Institutions and Nonprofits only